PMC:7755033 / 6343-6676 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"180","span":{"begin":77,"end":82},"obj":"Species"},{"id":"181","span":{"begin":94,"end":98},"obj":"Species"},{"id":"189","span":{"begin":148,"end":158},"obj":"Chemical"},{"id":"190","span":{"begin":168,"end":178},"obj":"Chemical"},{"id":"191","span":{"begin":180,"end":200},"obj":"Chemical"},{"id":"192","span":{"begin":208,"end":218},"obj":"Chemical"},{"id":"193","span":{"begin":220,"end":227},"obj":"Chemical"},{"id":"194","span":{"begin":233,"end":243},"obj":"Chemical"},{"id":"195","span":{"begin":245,"end":248},"obj":"Chemical"}],"attributes":[{"id":"A180","pred":"tao:has_database_id","subj":"180","obj":"Tax:9606"},{"id":"A181","pred":"tao:has_database_id","subj":"181","obj":"Tax:11118"},{"id":"A189","pred":"tao:has_database_id","subj":"189","obj":"MESH:D009705"},{"id":"A190","pred":"tao:has_database_id","subj":"190","obj":"MESH:C000606551"},{"id":"A191","pred":"tao:has_database_id","subj":"191","obj":"MESH:D000068698"},{"id":"A192","pred":"tao:has_database_id","subj":"192","obj":"MESH:C086979"},{"id":"A193","pred":"tao:has_database_id","subj":"193","obj":"MESH:C086979"},{"id":"A194","pred":"tao:has_database_id","subj":"194","obj":"MESH:D019259"},{"id":"A195","pred":"tao:has_database_id","subj":"195","obj":"MESH:D019259"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"atory tract infections.\nSeveral antiviral therapies have been identified for human pathogenic CoVs including synthetic inhibitors of neuraminidase, nucleoside analogs, remdesivir, tenofovir disoproxil (TDF), umifenovir (arbidol) and lamivudine (3TC) (Li et al., 2005). Studies involving identification of cellular receptors that faci"}

{"project":"LitCovid-sentences","denotations":[{"id":"T46","span":{"begin":24,"end":268},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"atory tract infections.\nSeveral antiviral therapies have been identified for human pathogenic CoVs including synthetic inhibitors of neuraminidase, nucleoside analogs, remdesivir, tenofovir disoproxil (TDF), umifenovir (arbidol) and lamivudine (3TC) (Li et al., 2005). Studies involving identification of cellular receptors that faci"}